Trial Profile
A Phase 2, Non-Randomized, Controlled, Open-Label, Parallel-Group, Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-pregnant Subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2023
Price :
$35
*
At a glance
- Drugs Streptococcal B vaccine conjugate (Primary)
- Indications Streptococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline; GlaxoSmithKline Biologicals; GSK
- 08 Aug 2019 Results published in the Clinical Infectious Diseases
- 10 Dec 2016 Status changed from active, no longer recruiting to completed.
- 14 Jul 2016 Status changed from recruiting to active, no longer recruiting.